Making Cancer Policy PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Making Cancer Policy PDF full book. Access full book title Making Cancer Policy by Mark E. Rushefsky. Download full books in PDF and EPUB format.
Author: Mark E. Rushefsky
Publisher: SUNY Press
ISBN: 9780887064067
Category : Social Science
Languages : en
Pages : 276
Get Book Here
Book Description
Mark Rushefsky confronts head-on the controversies surrounding federal cancer policy, within the context, however, of a balanced view of the politics and science involved. From 1976 to 1984, federal agencies such as the Consumer Product Safety Commission, the Environmental Protection Agency, the Food and Drug Administration, the Occupational Safety and Health Administration issued guidelines regulating public exposure to chemical carcinogens. These policies have engendered controversy and undergone numerous changes. Some of these are based on new scientific developments, others on new political developments. Making Cancer Policy analyzes the guidelines issued by these agencies in terms of their scientific and political environment. It addresses the issues of uncertainty in the scientific foundation of cancer policy, scientific controversies, the mixing of science and politics, and the political uses of science. This book shows just how "political" science can be.
Author: Mark E. Rushefsky
Publisher: SUNY Press
ISBN: 9780887064067
Category : Social Science
Languages : en
Pages : 276
Get Book Here
Book Description
Mark Rushefsky confronts head-on the controversies surrounding federal cancer policy, within the context, however, of a balanced view of the politics and science involved. From 1976 to 1984, federal agencies such as the Consumer Product Safety Commission, the Environmental Protection Agency, the Food and Drug Administration, the Occupational Safety and Health Administration issued guidelines regulating public exposure to chemical carcinogens. These policies have engendered controversy and undergone numerous changes. Some of these are based on new scientific developments, others on new political developments. Making Cancer Policy analyzes the guidelines issued by these agencies in terms of their scientific and political environment. It addresses the issues of uncertainty in the scientific foundation of cancer policy, scientific controversies, the mixing of science and politics, and the political uses of science. This book shows just how "political" science can be.
Author: Wendy N. Whitman Cobb
Publisher: Bloomsbury Publishing USA
ISBN:
Category : Political Science
Languages : en
Pages : 140
Get Book Here
Book Description
This book examines the politics of cancer, explains how our government is intrinsically tied to cancer research efforts, and documents how major political actors make cancer policy and are influenced in their decision making by political, social, scientific, and economic variables. Is whether we contract cancer—and whether we survive the disease, if we get it—largely just a result of good versus bad luck, or are these outcomes regarding cancer tied to the policies and actions of our federal government? Cancer-treating drug development and approval is overseen by the U.S. Food and Drug Administration, billions of dollars of federal money are devoted towards cancer research, and exposure of citizens to potentially cancer-causing environments or chemicals is regulated by the Environmental Protection Agency. Additionally, all of these factors can be affected by the political motivations of our most powerful politicians. The Politics of Cancer: Malignant Indifference analyzes the policy environment of cancer in America: the actors, the political institutions, the money, and the disease itself, identifying how haphazard U.S. government policy toward cancer research has been and how the president, Congress, government bureaucracies, and even the cancer industry have failed to meet timelines and make the expected discoveries. Whitman Cobb examines funding for the National Cancer Institute and the roles of the executive, Congress, policy entrepreneurs, and the bureaucracy as well as that of the state of cancer science. She argues that despite the so-called "war on cancer," no strategic, comprehensive government policy has been imposed—leading to an indecisive cancer policy that has significantly impeded cancer research. Written from a political science perspective, the book enables readers to gain insight into the realities of science policy and the ways in which the federal government is both the source of funding for much of cancer research and often deficient in setting comprehensive and consistent anti-cancer policy. Readers will also come to understand how Congress, the president, the bureaucracy, and the cancer industry all share responsibility for the current state of cancer policy confusion and consider whether pharmaceutical companies, for-profit cancer treatment hospitals, and interest groups like the American Cancer Society have a personal incentive to keep the fight alive.
Author: Samuel S. Epstein
Publisher:
ISBN:
Category : Health & Fitness
Languages : en
Pages : 804
Get Book Here
Book Description
"The Politics of Cancer Revisited," by internationally renowned authority on cancer causes and preventions, Samuel S. Epstein, M.D., backed by meticulous documentation, charges that the cancer establishment remains myopically fixated on damage control--diagnosis and treatment, and basic genetic research with, not always benign, indifference to cancer prevention research and failure of outreach to Congress, regulatory agencies, and the public with scientific information on unwitting exposures to a wide range of avoidable causes of cancer. The National Cancer Institute (NCI) and the American Cancer Society (ACS) are also accused of pervasive conflicts of interest, particularly with the cancer drug industry.
Author: Robert Proctor
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 372
Get Book Here
Book Description
Written by a highly regarded historian of science, this meticulouly researched, eminently fair, and very provocative book attempts to answer the question: Why, given all the time and money spent on cancer research, can't we get consistent answers to the most fundamental questions about prevention and treatment?
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages :
Get Book Here
Book Description
Author: Samuel S. Epstein
Publisher: Anchor Books
ISBN:
Category : Medical
Languages : en
Pages : 656
Get Book Here
Book Description
Author: Gerald E. Markle
Publisher: Routledge
ISBN: 1000307581
Category : Social Science
Languages : en
Pages : 266
Get Book Here
Book Description
At no time in U.S. history has there been a more effective challenge to medical expertise and authority than that mounted by the contemporary Laetrile movement. The efficacy of Laetrile has been debated for over twenty-five years, but despite vigorous opposition from the medical community, support for the purported cancer treatment continues to grow and the controversy has in recent years intensified and become highly politicized. How does one account for the continuing debate and the spectacular political growth of the movement to promote Laetrile? This and related questions are addressed by an interdisciplinary group of authors in this first scholarly analysis of the Laetrile phenomenon.
Author: Patricia Strach
Publisher: Oxford University Press
ISBN: 0190606878
Category : Political Science
Languages : en
Pages : 257
Get Book Here
Book Description
As late as the 1980s, breast cancer was a stigmatized disease, so much so that local reporters avoided using the word "breast" in their stories and early breast cancer organizations steered clear of it in their names. But activists with business backgrounds began to partner with corporations for sponsored runs and cause-marketing products, from which a portion of the proceeds would benefit breast cancer research. Branding breast cancer as "pink"--hopeful, positive, uncontroversial--on the products Americans see every day, these activists and corporations generated a pervasive understanding of breast cancer that is widely shared by the public and embraced by policymakers. Clearly, they have been successful: today, more Americans know that the pink ribbon is the symbol of breast cancer than know the name of the vice president. Hiding Politics in Plain Sight examines the costs of employing market mechanisms--especially cause marketing--as a strategy for change. Patricia Strach suggests that market mechanisms do more than raise awareness of issues or money to support charities: they also affect politics. She shows that market mechanisms, like corporate-sponsored walks or cause-marketing, shift issue definition away from the contentious processes in the political sphere to the market, where advertising campaigns portray complex issues along a single dimension with a simple solution: breast cancer research will find a cure and Americans can participate easily by purchasing specially-marked products. This market competition privileges even more specialized actors with connections to business. As well, cooperative market activism fundamentally alters the public sphere by importing processes, values, and biases of market-based action into politics. Market activism does not just bring social concerns into market transactions, it also brings market biases into public policymaking, which is inherently undemocratic. As a result, industry and key activists work cooperatively rather than contentiously, and they define issues as consensual rather than controversial, essentially hiding politics in plain sight.
Author: Abbe R. Gluck
Publisher: PublicAffairs
ISBN: 1541700627
Category : Medical
Languages : en
Pages : 416
Get Book Here
Book Description
An unprecedented constellation of experts—leading cancer doctors, policymakers, cutting-edge researchers, national advocates, and more—explore the legacy and the shortcomings from the fifty-year war on cancer and look ahead to the future. The longest war in the modern era, longer than the Cold War, has been the war on cancer. Cancer is a complex, evasive enemy, and there was no quick victory in the fight against it. But the battle has been a monumental test of medical and scientific research and fundraising acumen, as well as a moral and ethical challenge to the entire system of medicine. In A New Deal for Cancer, some of today’s leading thinkers, activists, and medical visionaries describe the many successes in the long war and the ways in which our deeper failings as a society have held us back from a more complete success. Together they present an unrivaled and nearly complete map of the battlefield across dimensions of science, government, equity, business, the patient provider experience, and more, documenting our emerging understanding of cancer’s many unique dimensions and offering bold new plans to enable the American health care system to deliver progress and hope to all patients.
Author: Lisa Keränen
Publisher: University of Alabama Press
ISBN: 081731704X
Category : Biography & Autobiography
Languages : en
Pages : 250
Get Book Here
Book Description
Scientific Characters chronicles the contests over character, knowledge, trust, and truth in a politically charged scientific controversy that erupted after a 1994 Chicago Tribune headline: "Fraud in Breast Cancer Research: Doctor Lied on Data for Decade." Moving back and forth between news coverage, medical journals, letters to the editor, and oncology pamphlets, Lisa Keränen draws insights from rhetoric, literary studies, sociology, and science studies to analyze the roles of character in shaping the outcomes of the "Datagate" controversy.
